" class="no-js "lang="en-US"> Peter Ding - Medtech Alert
Wednesday, March 27, 2024
Peter Ding

Peter Ding

About Peter Ding

Qiang Ding has near 20 years of experience in small molecule drug discovery, familiar to innovative drug pre-IND research and development, companion diagnosis strategy, IND filing both in US and China, and early stage dose escalation and POC clinical trial; Co-founder for two biotech startup companies – Curegenix and Allorion Therapeutics.

Related Story

Next-generation Precision Medicine Company Allorion Therapeutics Completes Series A Financing Round

November 24 2021

Allorion Therapeutics, a company focusing on next-generation precision medicine for oncology and autoimmune disease, today […]